DAWN — DAY ONE BIOPHARMACEUTICALS I
Public company
Sign in to save0 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Tracked investors currently reporting DAWN
6 tracked investors have since exited this position — listed separately below.
- No tracked investors hold this ticker.
Previously held DAWN
These investors reported DAWN in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Izzy Englander | Millennium Management | 1.9M | $41.3M | Mar 31, 2026 |
| Andreas Halvorsen | Viking Global Investors | 2.6M | $35.6M | Sep 30, 2024 |
| George Soros | Soros Fund Management | 1.5M | $33M | Mar 31, 2026 |
| Ken Griffin | Citadel Advisors | 418.7K | $9M | Mar 31, 2026 |
| Steve Cohen | Point72 Asset Management | 156.2K | $1.5M | Dec 31, 2025 |
| Paul Tudor Jones | Tudor Investment Corp | 49.6K | $349.3K | Sep 30, 2025 |
Recent activity
- $0(-100.00%)Feb 14, 2025
- New$33MMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- Sold$0(-100.00%)Nov 14, 2024
- New$2.5MAug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- New$1.5MFeb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- $767.8KNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $402.8KMay 15, 2025
- Reduced$236.6K(-28.35%)Aug 14, 2025
- Increased$349.3K(36.15%)Dec 9, 2025
- New$6.5MSep 16, 2024
- $35.6MNov 14, 2024